Gossamer Bio Inc (GOSS) — Financial Flexibility Index
Gossamer Bio Inc (GOSS) has a Financial Flexibility Index of -0.12x as of September 2025. Free cash flow of $-36.17 Million (operating CF $-36.17 Million minus capex $0.00) represents 0% of total liabilities ($291.15 Million). Check GOSS capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Gossamer Bio Inc Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Gossamer Bio Inc across 9 annual periods. See GOSS working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Gossamer Bio Inc (2016–2024)
Year-by-year free cash flow to debt coverage for Gossamer Bio Inc. For the full company profile including market capitalisation, see market cap of Gossamer Bio Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.01x | $-3.47 Million | $-3.47 Million | $285.80 Million | ▲ +98.1% |
| 2023 | -0.64x | $-159.16 Million | $-159.16 Million | $249.15 Million | ▲ +10.8% |
| 2022 | -0.72x | $-186.56 Million | $-187.03 Million | $260.37 Million | ▲ +15.0% |
| 2021 | -0.84x | $-187.27 Million | $-188.89 Million | $222.19 Million | ▼ -21.7% |
| 2020 | -0.69x | $-151.48 Million | $-176.36 Million | $218.75 Million | ▲ +62.9% |
| 2019 | -1.87x | $-138.27 Million | $-144.83 Million | $74.12 Million | ▼ -2147.9% |
| 2018 | -0.08x | $-29.83 Million | $-51.04 Million | $359.49 Million | ▲ +73.1% |
| 2017 | -0.31x | $-2.25 Million | $-5.75 Million | $7.31 Million | ▼ -101.6% |
| 2016 | 19.18x | $3.51 Million | $20.00K | $183.00K | — |